CSO Anders Sandberg interviewed in BioStock article on the presentation of ALZ-201 at CTAD
Date: 2022-12-02
Alzinova's CSO Anders Sandberg was interviewed about the Companies monoclonal antibody ALZ-201 that is presented in a poster presentation at the scientific conference - CTAD Clinical Trials on Alzheimer's Disease 29 November - 2 December.